Article
Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models.
Nature communications - 11 Aug 2016
Daniels Michael J D, Rivers-Auty Jack, Schilling Tom, Spencer Nicholas G, Watremez William, Fasolino Victoria, Booth Sophie J, White Claire S, Baldwin Alex G, Freeman Sally, Wong Raymond, Latta Clare, Yu Shi, Jackson Joshua, Fischer Nicolas, Koziel Violette, Pillot Thierry, Bagnall James, Allan Stuart M, Paszek Pawel, Galea James, Harte Michael K, Eder Claudia, Lawrence Catherine B, Brough David
Abstract excerpt
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase-1 (COX-1) and COX-2 enzymes. The NLRP3 inflammasome is a multi-protein complex responsible for the processing of the proinflammatory cytokine interleukin-1β and is implicated in many inflammatory diseases. Here we show that several clinically approved and widely used NSAIDs of the fenamate class are effective and selective inhibitors of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
